GLP-1 injections, which are used for weight loss, cost around $500 a month.

PrimeRx reports that independent pharmacies struggle to compete with big retailers like CVS and Walgreens due to pricing pressures and PBM influence, yet they maintain value through personalized care and community trust.

GoodRx reports Wegovy HD is a higher-dose version of Wegovy, offering potentially greater weight loss but with increased side effects.

GoodRx reports that medication lockboxes enhance safety, preventing accidental ingestion and misuse, especially in homes with children or controlled substances.

GoodRx reports that step therapy requires patients to try lower-cost medications before coverage for prescribed treatments.

Kivo reports that quality control significantly drives up prescription costs by ensuring safety and compliance in the pharmaceutical industry.

The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.

GoodRx reports on how to handle situations when medications aren't covered by insurance, offering tips for appeals, alternatives, and financial assistance.

The recall potentially affects more than 1 million people. It is the second time the FDA has found sterility issues at the company in three years.

Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and global supply chains.